Liposome News and Research

Latest Liposome News and Research

Millennium commences Vc-R-CHOP Phase II trial for diffuse large B-cell lymphoma

Millennium commences Vc-R-CHOP Phase II trial for diffuse large B-cell lymphoma

Celsion completes patient enrollment in its global Phase III ThermoDox trial

Celsion completes patient enrollment in its global Phase III ThermoDox trial

Positive results from Transave's Phase II ARIKACE clinical trials

Positive results from Transave's Phase II ARIKACE clinical trials

Philippines and Malaysian regulatory agencies approve Celsion’s Phase III Thermodox trial

Philippines and Malaysian regulatory agencies approve Celsion’s Phase III Thermodox trial

China's SFDA approves Celsion’s global Phase III ThermoDox HEAT trial for treating liver cancer

China's SFDA approves Celsion’s global Phase III ThermoDox HEAT trial for treating liver cancer

Celator Pharmaceuticals enrolls 120 patients in CPX-351 Phase 2 study

Celator Pharmaceuticals enrolls 120 patients in CPX-351 Phase 2 study

YM BioSciences to acquire Cytopia

YM BioSciences to acquire Cytopia

US Treasury Department clears YM BioSciences' nimotuzumab clinical program extension

US Treasury Department clears YM BioSciences' nimotuzumab clinical program extension

Research to improve the targeting of chemotherapeutic drugs to specific cells

Research to improve the targeting of chemotherapeutic drugs to specific cells

The ThermoDox and MR-HIFU program shows great promise for treating life-threatening cancers

The ThermoDox and MR-HIFU program shows great promise for treating life-threatening cancers

EGFR-targeted therapy improves survival rates in metastatic colorectal cancer patients

EGFR-targeted therapy improves survival rates in metastatic colorectal cancer patients

Bio-Path Holdings to develop liposome tumor targeting technology

Bio-Path Holdings to develop liposome tumor targeting technology

Celsion recommended to continue patient enrollment in its ThermoDox Phase III liver cancer trial

Celsion recommended to continue patient enrollment in its ThermoDox Phase III liver cancer trial

Millennium's sNDA for VELCADE granted priority review by the FDA

Millennium's sNDA for VELCADE granted priority review by the FDA

Nimotuzumab drug approved for Mexican distribution

Nimotuzumab drug approved for Mexican distribution

Celsion's DIGNITY clinical trial aired on Good Morning America

Celsion's DIGNITY clinical trial aired on Good Morning America

Positive results from Transave's Phase II clinical trial of ARIKACE in non-CF bronchiectasis patients

Positive results from Transave's Phase II clinical trial of ARIKACE in non-CF bronchiectasis patients

ALF, Celsion partner to educate physicians about primary liver cancer treatments

ALF, Celsion partner to educate physicians about primary liver cancer treatments

Abstracts on Merck Serono oncology treatments to be presented at ECCO and ESMO

Abstracts on Merck Serono oncology treatments to be presented at ECCO and ESMO

New Drug Application for trabectedin approved by the FDA

New Drug Application for trabectedin approved by the FDA